financetom
Business
financetom
/
Business
/
Boeing Faces Near-Term Risks From Upcoming Union Labor Contract Expiration, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing Faces Near-Term Risks From Upcoming Union Labor Contract Expiration, UBS Says
Aug 27, 2024 5:19 AM

04:11 PM EDT, 08/22/2024 (MT Newswires) -- Boeing ( BA ) faces potential near-term risks from the upcoming expiration of the union labor contract with 32,000 IAM 751 members on Sept. 13, UBS said in a note Thursday.

In the event of a strike, UBS outlines three potential scenarios, with the worst-case scenario involving an over two-month-long strike, potentially halting deliveries of key aircraft models like the Max, 777, and 767, leading to severe financial repercussions.

A failure to reach an agreement could lead to a strike, significantly impacting aircraft deliveries and creating an $8 billion cash flow headwind, the investment firm said.

Boeing's ( BA ) free cash flow estimates for 2024 to 2028 could be affected by wage increases, with an up to 6% potential impact depending on the scale of union wage increases, ranging from a 14% step-up to a 40% step-up, UBS said.

Despite these risks, UBS notes that even if a strike does not occur, Boeing ( BA ) will likely still face higher wage costs, leading to an estimated $1 billion increase in annual union wages by the end of the decade.

UBS had a buy rating for Boeing ( BA ) with a price target of $240.

Price: 172.76, Change: -0.17, Percent Change: -0.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exact Sciences's Multi-Cancer Early Detection Study Enrols First Patient
Exact Sciences's Multi-Cancer Early Detection Study Enrols First Patient
Aug 20, 2024
07:44 AM EDT, 08/20/2024 (MT Newswires) -- Exact Sciences ( EXAS ) said on Tuesday the first patient had joined its multi-cancer early detection falcon registry study at Baylor Scott & White, its primary study site in Texas. The company said the study, involving up to 25,000 patients, would assess the performance, experience, and impact of multi-cancer early detection testing...
Market Chatter: Walt Disney, Reliance Face India Antitrust Scrutiny Over Cricket
Market Chatter: Walt Disney, Reliance Face India Antitrust Scrutiny Over Cricket
Aug 20, 2024
08:05 AM EDT, 08/20/2024 (MT Newswires) -- India's antitrust watchdog has concluded preliminarily that the $8.5 billion merger of Walt Disney's ( DIS ) India assets and Reliance MediaWorks hurts competition, Reuters reported Tuesday, citing unnamed sources. The Competition Commission of India considers the two companies' potential domination of cricket broadcast rights the main obstacle, the report said. The watchdog...
Vecima Networks Announces First U.S.-made Electronics Equipment
Vecima Networks Announces First U.S.-made Electronics Equipment
Aug 20, 2024
08:00 AM EDT, 08/20/2024 (MT Newswires) -- Vecima Networks ( VNWTF ) on Tuesday said its first U.S.-made internet network electronics equipment will roll off the production line next week at MARA Technologies USA's Holly, Michigan manufacturing facility. The production is part of the Build America Buy America (BABA) requirements for the Broadband Equity Access and Deployment (BEAD) Program, the...
Tonix Pharmaceuticals Begins Phase 2 Trial of Cocaine Intoxication Treatment
Tonix Pharmaceuticals Begins Phase 2 Trial of Cocaine Intoxication Treatment
Aug 20, 2024
07:58 AM EDT, 08/20/2024 (MT Newswires) -- Tonix Pharmaceuticals ( TNXP ) said Tuesday its first patient was dosed in its phase 2, single-blind, placebo-controlled trial of TNX-1300 for treating acute cocaine intoxication in emergency departments. TNX-1300 is a recombinant enzyme that degrades and metabolizes cocaine in cocaine users. The trial will assess the safety and efficacy of a single...
Copyright 2023-2025 - www.financetom.com All Rights Reserved